Recent approaches in the drug research and development of novel antimalarial drugs with new targets

Malaria is a serious worldwide medical issue that results in substantial annual death and morbidity. The availability of treatment alternatives is limited, and the rise of resistant parasite types has posed a significant challenge to malaria treatment. To prevent a public health disaster, novel anti...

Full description

Saved in:
Bibliographic Details
Main Authors: Chinnappanna Naveen Kumar Reddy, Yennam Gopi, Chaitanya Chaitanya Budagam Haima Naga Venkata, Pottathil Shinu, Borah Pobitra, Venugopala Katharigatta N., Deb Pran Kishore, Mailavaram Raghu Prasad
Format: Article
Language:English
Published: Sciendo 2023-03-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2023-0001
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572845023035392
author Chinnappanna Naveen Kumar Reddy
Yennam Gopi
Chaitanya Chaitanya Budagam Haima Naga Venkata
Pottathil Shinu
Borah Pobitra
Venugopala Katharigatta N.
Deb Pran Kishore
Mailavaram Raghu Prasad
author_facet Chinnappanna Naveen Kumar Reddy
Yennam Gopi
Chaitanya Chaitanya Budagam Haima Naga Venkata
Pottathil Shinu
Borah Pobitra
Venugopala Katharigatta N.
Deb Pran Kishore
Mailavaram Raghu Prasad
author_sort Chinnappanna Naveen Kumar Reddy
collection DOAJ
description Malaria is a serious worldwide medical issue that results in substantial annual death and morbidity. The availability of treatment alternatives is limited, and the rise of resistant parasite types has posed a significant challenge to malaria treatment. To prevent a public health disaster, novel antimalarial agents with single-dosage therapies, extensive curative capability, and new mechanisms are urgently needed. There are several approaches to developing antimalarial drugs, ranging from alterations of current drugs to the creation of new compounds with specific targeting abilities. The availability of multiple genomic techniques, as well as recent advancements in parasite biology, provides a varied collection of possible targets for the development of novel treatments. A number of promising pharmacological interference targets have been uncovered in modern times. As a result, our review concentrates on the most current scientific and technical progress in the innovation of new antimalarial medications. The protein kinases, choline transport inhibitors, dihydroorotate dehydrogenase inhibitors, isoprenoid biosynthesis inhibitors, and enzymes involved in the metabolism of lipids and replication of deoxyribonucleic acid, are among the most fascinating antimalarial target proteins presently being investigated. The new cellular targets and drugs which can inhibit malaria and their development techniques are summarised in this study.
format Article
id doaj-art-e3844dd855d9495690923ed3afb65200
institution Kabale University
issn 1846-9558
language English
publishDate 2023-03-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-e3844dd855d9495690923ed3afb652002025-02-02T07:31:15ZengSciendoActa Pharmaceutica1846-95582023-03-0173112710.2478/acph-2023-0001Recent approaches in the drug research and development of novel antimalarial drugs with new targetsChinnappanna Naveen Kumar Reddy0Yennam Gopi1Chaitanya Chaitanya Budagam Haima Naga Venkata2Pottathil Shinu3Borah Pobitra4Venugopala Katharigatta N.5Deb Pran Kishore6Mailavaram Raghu Prasad7Shri Vishnu College of Pharmacy, B.V Raju group of Institutions, Vishnupur, Bhimavaram West Godavari District, Andhra Pradesh 534202IndiaShri Vishnu College of Pharmacy, B.V Raju group of Institutions, Vishnupur, Bhimavaram West Godavari District, Andhra Pradesh 534202IndiaShri Vishnu College of Pharmacy, B.V Raju group of Institutions, Vishnupur, Bhimavaram West Godavari District, Andhra Pradesh 534202IndiaDepartment of Biomedical Sciences, College of Clinical Pharmacy, King Faisal UniversityAl-Ahsa31982, Kingdom of Saudi ArabiaSchool of Pharmacy, Graphic Era Hill UniversityDehradun248002, Uttarakhand, IndiaDepartment of Biotechnology and Food Science Faculty of Applied Sciences, Durban University of Technology, Durban, 4000South AfricaDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, Amman19392JordanDepartment of Pharmaceutical Chemistry, Shri Ville Parle Kelavani Mandal’s Institute of Pharmacy Survey No. 499, Plot No 03, Mumbai – Agra National Hwy, Behind Gurudwara, Samta Nagar Dhule, Maharashtra424001Malaria is a serious worldwide medical issue that results in substantial annual death and morbidity. The availability of treatment alternatives is limited, and the rise of resistant parasite types has posed a significant challenge to malaria treatment. To prevent a public health disaster, novel antimalarial agents with single-dosage therapies, extensive curative capability, and new mechanisms are urgently needed. There are several approaches to developing antimalarial drugs, ranging from alterations of current drugs to the creation of new compounds with specific targeting abilities. The availability of multiple genomic techniques, as well as recent advancements in parasite biology, provides a varied collection of possible targets for the development of novel treatments. A number of promising pharmacological interference targets have been uncovered in modern times. As a result, our review concentrates on the most current scientific and technical progress in the innovation of new antimalarial medications. The protein kinases, choline transport inhibitors, dihydroorotate dehydrogenase inhibitors, isoprenoid biosynthesis inhibitors, and enzymes involved in the metabolism of lipids and replication of deoxyribonucleic acid, are among the most fascinating antimalarial target proteins presently being investigated. The new cellular targets and drugs which can inhibit malaria and their development techniques are summarised in this study.https://doi.org/10.2478/acph-2023-0001antimalarial drugsprotein kinasesdihydroorotate dehydrogenase
spellingShingle Chinnappanna Naveen Kumar Reddy
Yennam Gopi
Chaitanya Chaitanya Budagam Haima Naga Venkata
Pottathil Shinu
Borah Pobitra
Venugopala Katharigatta N.
Deb Pran Kishore
Mailavaram Raghu Prasad
Recent approaches in the drug research and development of novel antimalarial drugs with new targets
Acta Pharmaceutica
antimalarial drugs
protein kinases
dihydroorotate dehydrogenase
title Recent approaches in the drug research and development of novel antimalarial drugs with new targets
title_full Recent approaches in the drug research and development of novel antimalarial drugs with new targets
title_fullStr Recent approaches in the drug research and development of novel antimalarial drugs with new targets
title_full_unstemmed Recent approaches in the drug research and development of novel antimalarial drugs with new targets
title_short Recent approaches in the drug research and development of novel antimalarial drugs with new targets
title_sort recent approaches in the drug research and development of novel antimalarial drugs with new targets
topic antimalarial drugs
protein kinases
dihydroorotate dehydrogenase
url https://doi.org/10.2478/acph-2023-0001
work_keys_str_mv AT chinnappannanaveenkumarreddy recentapproachesinthedrugresearchanddevelopmentofnovelantimalarialdrugswithnewtargets
AT yennamgopi recentapproachesinthedrugresearchanddevelopmentofnovelantimalarialdrugswithnewtargets
AT chaitanyachaitanyabudagamhaimanagavenkata recentapproachesinthedrugresearchanddevelopmentofnovelantimalarialdrugswithnewtargets
AT pottathilshinu recentapproachesinthedrugresearchanddevelopmentofnovelantimalarialdrugswithnewtargets
AT borahpobitra recentapproachesinthedrugresearchanddevelopmentofnovelantimalarialdrugswithnewtargets
AT venugopalakatharigattan recentapproachesinthedrugresearchanddevelopmentofnovelantimalarialdrugswithnewtargets
AT debprankishore recentapproachesinthedrugresearchanddevelopmentofnovelantimalarialdrugswithnewtargets
AT mailavaramraghuprasad recentapproachesinthedrugresearchanddevelopmentofnovelantimalarialdrugswithnewtargets